Investors Urged to Join Class Action Against Reckitt Benckiser Group by August 2025

Investors in Reckitt Benckiser Group plc, known by its OTCQX ticker RBGLY, are being notified about a significant class action lawsuit that has emerged, spearheaded by the law firm Levi & Korsinsky. This legal move is aimed at addressing alleged violations of securities laws that have adversely impacted shareholders during the period from January 13, 2021, to July 28, 2024.

Case Overview

The lawsuit seeks to recover losses for investors who may have suffered due to claims of securities fraud. The complaint asserts that Reckitt Benckiser made misleading statements regarding its cow's milk-based formula, Enfamil, particularly its effects on preterm infants. Allegations state that the company concealed the heightened risk of necrotizing enterocolitis (NEC) associated with this product, which consequently misrepresented the company's sales and exposure to potential legal claims.

Key Allegations

The main allegations include:
1. The company did not adequately inform the public about the increased health risks for preterm infants being fed Enfamil.
2. There was a lack of transparency concerning the potential impact on future sales and ongoing legal issues surrounding the product.
3. As a result, the positive statements made by the company regarding its business health were found to be materially false and misleading.

Next Steps for Investors

Affected shareholders have until August 4, 2025, to take necessary actions if they wish to participate in the lawsuit. Investors are encouraged to reach out to Levi & Korsinsky to discuss their rights and see if they qualify to be appointed as lead plaintiffs. It’s important to note that while becoming a lead plaintiff may benefit your standing in the class action, all investors might still be eligible for compensation regardless of this title.

No Financial Burden

Investors should be aware that participating in this class action comes with no out-of-pocket costs or obligations. If you're a verified member of the class, you could secure compensation without financial risk.

Why Levi & Korsinsky?

Levi & Korsinsky has built a robust reputation over the past two decades, recovering hundreds of millions of dollars for investors and consistently ranking as one of the top securities litigation firms in the United States. Their team comprises over 70 professionals dedicated to serving clients who have faced losses in complex securities disputes.

Contact Information

Investors are strongly encouraged to visit Levi & Korsinsky or directly reach out to Joseph E. Levi at (212) 363-7500 or via email at [email protected]. For those looking to explore the potential for class action participation or seeking further information, detailed instructions can be found on the law firm's website.

Conclusion

The class action against Reckitt Benckiser Group plc not only highlights serious allegations tied to shareholder fraud but also serves as a critical reminder for investors to stay vigilant about the implications of corporate disclosures. If you have stood behind Reckitt Benckiser during the specified timeframe, now is the time to act and understand the protections available to you as an investor.